India’s Ministry of Health has unveiled a groundbreaking initiative aimed at screening and providing standardized care to 75 million individuals living with hypertension and diabetes by 2025. The announcement was made on World Hypertension Day during the “Accelerating the Prevention and Management of Hypertension and Diabetes” event, jointly organized by the ministry and the World Health Organization (WHO), as part of the G20 co-branded initiative.
Dr. V K Paul, a member of NITI Aayog (the National Institution for Transforming India) and an expert in healthcare, emphasized the innovative nature of the scheme. He stated that this initiative will be the largest expansion of non-communicable disease (NCD) management in primary healthcare worldwide, adopting a community-based approach starting at the primary healthcare level.
The initiative recognizes the growing burden of hypertension and diabetes in India, both of which are major contributors to cardiovascular diseases and associated complications. With over 200 million people estimated to be living with hypertension and diabetes in the country, there is an urgent need for comprehensive and accessible care to mitigate the impact of these conditions.
The program aims to tackle the challenge by screening individuals for hypertension and diabetes, enabling early detection and intervention. Once identified, individuals will be enrolled in a standardized care program, which will provide them with essential medications, regular check-ups, lifestyle counseling, and education to manage their conditions effectively.
By adopting a community-based approach, the initiative aims to bring healthcare services closer to the people, particularly at the primary healthcare level. This approach will involve training and mobilizing a large number of healthcare workers, including doctors, nurses, and community health volunteers, to deliver comprehensive care to individuals in their local communities.
To support the initiative, the Ministry of Health will collaborate with various stakeholders, including state governments, civil society organizations, and international partners. The World Health Organization (WHO) will provide technical expertise and guidance, drawing upon its global experience in managing NCDs.
The ambitious goal of reaching 75 million people with hypertension and diabetes by 2025 reflects the government’s commitment to addressing the growing burden of NCDs in India. By focusing on prevention, early detection, and standardized care, the initiative aims to reduce the complications associated with hypertension and diabetes, improve the quality of life for affected individuals, and ultimately reduce the burden on the healthcare system.
This initiative marks a significant milestone in India’s efforts to combat NCDs and demonstrates the country’s commitment to prioritizing the health and well-being of its citizens. By leveraging a community-based approach and collaborating with key stakeholders, India is taking a proactive stance in managing hypertension and diabetes, setting an example for other nations grappling with similar challenges.
As the program unfolds over the coming years, monitoring and evaluation will play a crucial role in assessing its impact and identifying areas for improvement. Through continuous learning and refinement, India’s initiative has the potential to serve as a model for other countries seeking to address the growing burden of NCDs and enhance primary healthcare services.
